Posted on
Introducing the Noctura 400
Andrew, Sarah and the team are excited to be involved in a new commercial pilot of a revolutionary treatment for Diabetic Retinopathy, starting next month. Diabetic Retinopathy can cause reduced vision and blindness. Clinical trials have given hope that the new Noctura 400 sleep mask will reduce the number of people needing invasive treatment such as laser treatment and eye injections by reducing the amount of oxygen the eyes need overnight.
Please contact us if you would like to find out more.
